| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |